Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 5;7(5):ofaa150.
doi: 10.1093/ofid/ofaa150. eCollection 2020 May.

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol

Affiliations

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol

Michael Dagher et al. Open Forum Infect Dis. .

Abstract

Cefiderocol is a novel catechol siderophore cephalosporin antibiotic developed to treat resistant gram-negative infections. We describe its successful use as rescue therapy, combined with surgical debridement, to treat a patient with osteomyelitis due to extensively drug-resistant Acinetobacter baumannii. Bacterial whole-genome sequencing identified the strain and antibiotic resistance determinants.

Keywords: Acinetobacter baumannii; antimicrobial resistance; cefiderocol; osteomyelitis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Timeline of events. aOutpatient dose gradually increased to 2 g q24H to maintain vancomycin levels of 10–15 mcg/mL. b2.5 mg/kg loading dose then 1.5mg/kg q12H. c8 mg/kg q24H. d2 g q12H. e100 mg loading dose then 50 mg q12H. Abbreviations: AKI, acute kidney injury; Cr, creatinine; ED, emergency department; Pip./Tazo., pipericillin-tazobactam; TMP-SMX, trimethoprim-sulfamethoxazole.

References

    1. Ito A, Nishikawa T, Matsumoto S, et al. . Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2016; 60:7396–401. - PMC - PubMed
    1. Dobias J, Dénervaud-Tendon V, Poirel L, Nordmann P. Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant gram-negative pathogens. Eur J Clin Microbiol Infect Dis 2017; 36:2319–27. - PubMed
    1. Trecarichi EM, Quirino A, Scaglione V, et al. ; IMAGES Group Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. J Antimicrob Chemother 2019; 74:3399–401. - PubMed
    1. US Food and Drug Administration. Highlights of Prescribing Information: Fetroja (Cefiderocol). US Food and Drug Administration; 2019.
    1. Wattam AR, Davis JJ, Assaf R, et al. . Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center. Nucleic Acids Res 2017; 45:D535–42. - PMC - PubMed